© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 15, 1171-1173,
August 1, 2001
© 2001 Oxford University Press
BRIEF COMMUNICATION |
cis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome
Affiliation of authors: Laboratory of Biosystems and Cancer, Cancer and Aging Section, Division of Basic Sciences, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Correspondence to: Izumi Horikawa, Ph.D., National Institutes of Health, Bldg. 40, Rm. 2609, MSC-3020, Bethesda, MD 208923020 (e-mail: horikawi@mail.nih.gov).
Telomerase catalyzes the elongation of telomeric repeat DNA to maintain telomere length and structure (1). Although telomerase is a complex composed of a catalytic subunit (hTERT) and an RNA component (hTER), it is the expression of hTERT (2,3) that is the major determinant of telomerase activity in human cells (1,4). Maintaining telomere length by telomerase is associated with human cell immortalization and oncogenesis (1); however, no mutations in the hTERT or hTER telomerase genes have been found in human cancers. Hepatocellular carcinoma is often associated with both telomerase activation and viral infection. Here, we show the cis-activation of the hTERT gene by an insertion of viral DNA into the hTERT promoter region.
A 66-base-pair (bp) sequence within the promoter region of hTERT gene (positions -372 to -307) (Fig. 1
,
REFERENCES
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F Luan, H Liu, L Gao, J Liu, Z Sun, Y Ju, N Hou, C Guo, X Liang, L Zhang, et al. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT Gut, November 1, 2009; 58(11): 1528 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bellon and C. Nicot Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control J Natl Cancer Inst, January 16, 2008; 100(2): 98 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Katzenellenbogen, E. M. Egelkrout, P. Vliet-Gregg, L. C. Gewin, P. R. Gafken, and D. A. Galloway NFX1-123 and Poly(A) Binding Proteins Synergistically Augment Activation of Telomerase in Human Papillomavirus Type 16 E6-Expressing Cells J. Virol., April 15, 2007; 81(8): 3786 - 3796. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Murakami, K Saigo, H Takashima, M Minami, T Okanoue, C Brechot, and P Paterlini-Brechot Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas Gut, August 1, 2005; 54(8): 1162 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Lanson Jr., P. L. Friedlander, P. Schwarzenberger, J. K. Kolls, and G. Wang Replication of an Adenoviral Vector Controlled by the Human Telomerase Reverse Transcriptase Promoter Causes Tumor-Selective Tumor Lysis Cancer Res., November 15, 2003; 63(22): 7936 - 7941. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Horikawa and J. C. Barrett Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms Carcinogenesis, July 1, 2003; 24(7): 1167 - 1176. [Abstract] [Full Text] [PDF] |
||||




